"2024 is an exciting year where we closed our National Instruments acquisition, did excellent work driving synergies and integration and celebrated 80 years as a company listed on the New York Stock Exchange."
— Lal Karsanbhai
03Detailed Report
EMR
Company EMR
Period
Q4 2024
CurrencyUSD
Report TypeQuarterly Earnings
GeneratedMay 30, 2026
Swipe to view all report sections
Executive Summary
Emerson Electric Co. reported a solid Q4 2024 with a strong finish to a transformative year. Revenue of $4.62 billion generated a gross margin of 51.3% and an operating margin of 17.1%, underscoring a high-quality, high-margin portfolio that benefited from price discipline and ongoing cost reductions. For the full year, EMR delivered gross margins of 50.8% (a record for the company) and adjusted segment EBITDA of 26%, with full-year free cash flow of $2.9 billion and adjusted EPS of $5.49, reflecting the benefits of a higher-growth, higher-margin portfolio post-transformation. Management reaffirmed a disciplined capital-allocation stance, including a roughly $2.0 billion stock-repurchase plan for 2025 and continued dividend growth, while signaling the strategic culmination of portfolio actions (AspenTech integration and the Safety & Productivity review). The company guided 2025 adj. EPS of $5.85–$6.05, underlying sales growth of 3–5%, and free cash flow of $3.2–$3.3 billion, with AspenTech contributing roughly $0.44–$0.46 per share and Safety & Productivity contributing about $0.48 per share. Notably, EMR closed 2024 with a backlog of $7.2 billion (ex-T&M backlog up by $150 million), highlighting robust project momentum in process/hybrid markets and a positive signal for 2025 growth, albeit with continued reliance on capital-project cycles and LNG/energy-transition activity. The Q4 performance and 2025 outlook reflect a well-positioned, software-enabled industrial technology company facing a multi-year growth runway driven by software content, enterprise data fabric, and digital transformation across brownfield and greenfield environments.
Key Performance Indicators
Revenue
Increasing
4.62B
QoQ: 5.46% | YoY: 12.93%
Gross Profit
Increasing
2.37B
51.33% margin
QoQ: 15.83% | YoY: 17.84%
Operating Income
Increasing
790.00M
QoQ: -0.38% | YoY: 13.34%
Net Income
Increasing
996.00M
QoQ: 202.74% | YoY: 33.87%
EPS
Increasing
1.75
QoQ: 201.72% | YoY: 34.62%
Revenue Trend
Margin Analysis
Financial Highlights
Revenue: $4.619B in Q4 2024; YoY revenue growth 12.9%, QoQ growth 5.46% (per earnings data). Gross margin: 51.33% in Q4; full-year gross margin 50.8% (record). Operating margin: 17.1% in Q4; 2024 adjusted EBITDA margin: 26% (up 100 bps YoY). Net income: $996M in Q4; full-year net income growth ~33.9% YoY. EPS (GAAP): $1.75 (Q4); diluted $1.74; full-year adjusted EPS: $5.49, up 24% YoY. Backlog: $7.2B at year-end 2024; ex-T&M backlog growth of $150M. Free cash flow: $916M in Q4; full-year FCF: $2.9B, FCF margin 16.6%. Cash/debt: cash $3.588B; total debt $8.198B; net debt $4.61B; net debt/EBITDA under ~2x post-transactions expected. ROE ~4.6%; current ratio 1.78; debt-to-capitalization ~27.5%. Dividend yield ~0.48% as of latest data; share repurchases anticipated around $2B in 2025 (with ~$1B in Q1). Backdrop: 6% underlying sales growth in 2024 driven by process/hybrid; 8% ACV growth at AspenTech (2024) and 10% ACV growth projected post-integration.
Income Statement
Metric
Value
YoY Change
QoQ Change
Revenue
4.62B
12.93%
5.46%
Gross Profit
2.37B
17.84%
15.83%
Operating Income
790.00M
13.34%
-0.38%
Net Income
996.00M
33.87%
202.74%
EPS
1.75
34.62%
201.72%
Key Financial Ratios
Gross Profit Margin
Good
51.30%
Gross profit margin is healthy and competitive within industry standards
Operating Profit Margin
Good
17.10%
Operating margin is healthy and competitive within industry standards
Net Profit Margin
Excellent
21.60%
Net profit margin is exceptional, indicating strong pricing power and operational efficiency
Return on Assets
Weak
2.25%
Return on assets suggests inefficient capital allocation
Return on Equity
Weak
4.60%
Return on equity suggests inefficient capital allocation
Current Ratio
Healthy
1.78
Current ratio shows adequate liquidity to meet short-term obligations
Debt to Equity
Moderate
0.38
Debt-to-equity indicates balanced capital structure with manageable debt
P/E Ratio
Fair Value
15.65x
P/E ratio in line with market averages
Price to Book
Fair Value
2.88x
Price-to-book ratio reasonable for profitable companies
Management Insights Available for Members
Get exclusive access to management commentary, earnings call quotes, and forward guidance from company leadership.
Emerson Electric Co (EMR) QQ2 2025 Earnings Analysis: Margin Leadership, AspenTech Integration, and Tariff Mitigation amid Mixed Discrete and Process ...
Emerson Electric Co (EMR) QQ3 2024 Earnings Analysis: Margin Expansion, Copeland Monetization, and Steady Underlying Growth in a Transforming Portfoli...
Emerson Electric Co. (EMR) QQ2 2024 Earnings Review: Process & Hybrid Strength, Margin Expansion, and Synergy-Driven Outlook Across Automation Portfol...